F257-2130 Screening compound: 2,6-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-N-methylbenzamide

F257-2130 Screening compound: 2,6-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-N-methylbenzamide
F257-2130 Screening compound: 2,6-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-N-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F257-2130
2,6-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-N-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F257-2130

Molecular Formula

C20H19F2N3O4 (C20 H19 F2 N3 O4)

Compound Name

2,6-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)-N-methylbenzamide

IUPAC name

26-difluoro-N-(2-{5-[(4-methoxyphenoxy)methyl]-124-oxadiazol-3-yl}ethyl)-N-methylbenzamide

SMILES

CN(CCc1noc(COc(cc2)ccc2OC)n1)C(c(c(F)ccc1)c1F)=O

InChI

InChI=1S/C20H19F2N3O4/c1-25(20(26)19-15(21)4-3-5-16(19)22)11-10-17-23-18(29-24-17)12-28-14-8-6-13(27-2)7-9-14/h3-9H,10-12H2,1-2H3

InChI Key

ZJNHYLCQWNHNSI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27110570

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

403.39

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.846

Distribution Coefficient, logD

2.846

Water Solubility, LogSw

-3.16

Polar Surface Area

63.744

Acid Dissociation Constant (pKa)

28.29

Base Dissociation Constant (pKb)

-2.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

F257-2130 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F257-2130 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F257-2130?
Check Price and Availability of F257-2130, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F257-2130 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F257-2130
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F257-2130
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F257-2130 available by request